Insiders Bristol-Myers Squibb Company

Stocks

BMY

US1101221083

Pharmaceuticals

Market Closed - Nyse Other stock markets 21:00:02 08/06/2026 BST			After hours 01:00:00
55.57 ^USD	-2.97%		49.74	-10.50%

06-03	Arcus Biosciences Partners With Bristol Myers Squibb to Develop Kidney Cancer Treatment	MT
06-03	Arcus to Supply Experimental Kidney Cancer Drug for Myers Squibb Trial	DJ

Insiders

04-02	Bristol Myers Squibb Insider Sold Shares Worth $1,850,016, According to a Recent SEC Filing	MT
03-23	Insitro And Bristol Myers Squibb Expand Collaboration With Nomination Of New Targets	CI
04/09/25	Bristol Myers Squibb Insider Sold Shares Worth $2,650,480, According to a Recent SEC Filing	MT
25/07/25	Bristol-Myers Squibb Names Cristian Massacesi as Chief Medical Officer	MT
25/07/25	Bristol Myers Squibb Announces Management Changes	CI
06/05/25	Bristol Myers Squibb Announces Executive Changes	CI
18/02/25	Bristol-Myers Squibb Company Announces Retirement of Sandra Leung as Executive Vice President, General Counsel	CI
19/06/24	Bristol Myers: ex-CEO of Agilent joins Board of Directors
18/06/24	Bristol Myers Squibb Appoints Michael R. McMullen as Independent Director and Member of the Audit Committee, Effective July 1, 2024	CI
18/03/24	Bristol-Myers Squibb Company Announces Gerald Storch Not to Stand for Re-Election to the Board	CI
20/02/24	Aurora Cannabis Names Simona King CFO; Completes Share Consolidation	MT
15/02/24	Bristol-Myers Squibb Company Announces Management Changes	CI
09/01/24	Christopher Boerner, CEO of Bristol-Myers: A pipeline of 16 treatments, with a focus on neuroscience and oncology	MT
01/12/23	Bristol Myers Squibb Insider Bought Shares Worth $150,049, According to a Recent SEC Filing	MT
22/11/23	Bristol Myers Squibb Insider Bought Shares Worth $423,385, According to a Recent SEC Filing	MT
01/11/23	Bristol-Myers Squibb Names Christopher Boerner as Chair	MT
31/10/23	Bristol Myers Names Incoming CEO Boerner as Next Chairman	DJ
31/10/23	Bristol Myers Squibb Appoints Christopher Boerner as Chief Executive Officer	CI
31/10/23	Bristol Myers Squibb Announces Management Changes	CI
04/05/23	Insider Sell: Bristol Myers Squibb	MT
26/04/23	Bristol-Myers Squibb Company Announces Retirement of Giovanni Caforio as Chief Executive Officer	CI
26/04/23	Bristol-Myers Squibb Announces Transition of Leadership Plan	CI
31/01/23	Bristol-Myers Squibb Company Announces Resignation of Dr. Rupert Vessey, Executive Vice President, Research and Early Development, Effective July 3, 2023	CI
15/11/22	Insider Sell: Bristol Myers Squibb	MT
10/11/22	Insider Sell: Bristol Myers Squibb	MT